Klinefelter S Syndrome Xxy — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for klinefelter s syndrome xxy. 39 active patents protecting 2 drugs from 2+ originators. First major cliff: 2039. Daily refresh.

2
Approved drugs
39
Active US patents
62/100
Avg vulnerability
—
Annual revenue covered

Originators in Klinefelter S Syndrome Xxy

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Besins Hlthcare 36 patents Azurity 3 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating klinefelter s syndrome xxy. Each bar = one year. Y-axis scaled to peak year (24 patents).

24
26
4
27
8
34
3
39

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Androgel
TESTOSTERONE
 Besins Hlthcare 36 72 — 2026-10-12
Testosterone Cypionate
Testosterone Cypionate
 Azurity 3 52 — 2039-03-25

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8466137 Androgel method of use 85 2026-10-12
8741881 Androgel method of use 85 2026-10-12
8741881 Androgel method of use 85 2026-10-12
8741881 Androgel method of use 85 2026-10-12
8466138 Androgel method of use 85 2026-10-12
8466138 Androgel method of use 85 2026-10-12
8466137 Androgel method of use 85 2026-10-12
8466138 Androgel method of use 85 2026-10-12
8466137 Androgel method of use 85 2026-10-12
8419307 Androgel method of use 85 2027-02-26

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
11311554 Testosterone Cypionate formulation 50 2039-03-25
11642355 Testosterone Cypionate formulation 50 2039-03-25
12138271 Testosterone Cypionate formulation 55 2039-03-25
11090312 Androgel method of use 62 2034-03-17
9295675 Androgel method of use 62 2034-02-11
9295675 Androgel method of use 62 2034-02-11
9662340 Androgel method of use 62 2034-02-11
9662340 Androgel method of use 62 2034-02-11
8466136 Androgel formulation 65 2026-10-12
8754070 Androgel formulation 65 2026-10-12

Related